GSK Investigational Site [clinicaltrials_resource:a3353581a873f7d7c72281af6202cb5c]
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis [clinicaltrials:NCT00097331]GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol [clinicaltrials:NCT00158899]Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery [clinicaltrials:NCT00290355]clinicaltrials:NCT00805389clinicaltrials:NCT00875485clinicaltrials:NCT01147900Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults [clinicaltrials:NCT01767402]Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers [clinicaltrials:NCT02153320]
location [clinicaltrials_vocabulary:location]
GSK Investigational Site [clinicaltrials_resource:a3353581a873f7d7c72281af6202cb5c]
Bio2RDF identifier
a3353581a873f7d7c72281af6202cb5c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a3353581a873f7d7c72281af6202cb5c
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:a3353581a873f7d7c72281af6202cb5c
title
GSK Investigational Site
@en
type
label
GSK Investigational Site [clinicaltrials_resource:a3353581a873f7d7c72281af6202cb5c]
@en